Navigation Links
FDA Adds New Label Warnings to Over-the-Counter Painkillers
Date:4/28/2009

Acetaminophen, NSAIDs can cause liver or stomach illness in certain situations, officials warn,,,,

TUESDAY, April 28 (HealthDay News) -- Many over-the-counter painkillers and fever reducers will have to carry new warnings on the potential danger of liver damage and stomach bleeding, U.S. health officials said Tuesday.

Manufacturers will have to include these warnings on all their over-the-counter products containing acetaminophen (best known as Tylenol), and on all non-steroidal anti-inflammatory drugs (NSAIDs) drugs, according to new rules from the U.S. Food and Drug Administration (FDA).

NSAIDs include popular medicines such as aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve) and Excedrin.

"The regulations affect much of the U.S. population, because over-the-counter pain relievers and fever reducers are some of the most commonly used drugs," Matthew Holman, deputy director of FDA's Division of Nonprescription Regulation Development in the Office of Nonprescription Products, said during a late morning teleconference Tuesday.

The warnings also apply to any over-the-counter drug that contains acetaminophen and NSAIDs mixed with other drugs, Holman said.

The purpose of the new labeling is to raise awareness of potential liver damage from acetaminophen and the potential for stomach bleeding from NSAIDs, Holman said.

Products with acetaminophen will carry the warning that it may cause severe liver damage if you take more than the maximum daily dose or if you are also taking other drugs with acetaminophen, or if you have three or more drinks a day while taking the drug.

In addition, the label will also include a warning on using acetaminophen when taking the blood thinner warfarin, Holman said. People taking warfarin should ask their doctor about taking acetaminophen before they start the drug, he said.

"Every over-the-counter product containing a NSAID will have to
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Prescription labels geared toward pharmacies, not patients
2. FDA: Use the Nutrition Facts Label to Make Healthy Food Choices
3. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
4. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. IOM workshop on less confusing drug labeling, Oct. 12
8. FDA Expands VELCADE(R) (Bortezomib) for Injection Label for Patients with Multiple Myeloma
9. National Patient Advocate Foundation (NPAF) Statement Regarding New FDA Label on Erythropoietin Stimulating Agents (ESAs)
10. National Kidney Foundations 27th Annual Kidney Ball Featuring Entertainment by Patti LaBelle
11. GSK Revises US Labeling for Avandia(R)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Adds New Label Warnings to Over-the-Counter Painkillers
FDA Adds New Label Warnings to Over-the-Counter Painkillers
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...l Will Retain Decision Resources, Clinical Gold St... a New Report from Decision Resources , , WALTHAM...world,s leading research and advisory firms for ph...e attribute that most influences their prescribing...
...ws those who respond to lapatinib survive longer, ...he drug lapatinib could be used to treat aggressiv... of a phase 2 study. , Inflammatory breast cancer...apid onset of swelling, redness of breast skin, a ...
...ds they test higher than unmedicated peers in grad...ews) -- Children who take medication to treat atte...ter in elementary school than those who don,t, a n...h tests and 5.4 points higher on reading tests tha...
...nt Clinton supports global tribute to inspire peop...l 27 46664 and the Nelson Mandela Foundation are ...creation of an official Mandela Day , to be held ...heir individual power to make an imprint and help ...
...TON, April 27 A study of child development and un...SA is the first to link age-appropriate safety t...en,s cognitive, behavioral and physical developmen... parents how to keep their kids safe, but this rep...
...ly invasive varicose vein treatment market is larg...rch Group , , WALTHAM, Mass., April 27 According...ties in Brazil : Varicose Vein Treatment Devi...tment device market in the country, widely conside...
Other Medicine News:Health News:For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms 2Health News:For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms 3Health News:Drug May Help Against Inflammatory Breast Cancer 2Health News:Meds Help Kids With ADHD in Classroom 2Health News:Meds Help Kids With ADHD in Classroom 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 2Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 3Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 4Health News:46664 and the Nelson Mandela Foundation Call for Establishment of Global 'Mandela Day' 5Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 2Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 3Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 4Health News:Connecting the Dots: For the First Time a Safety Report Links Research on a Child's Development and the Risk of Unintentional Injury With Age-Appropriate Safety Recommendations 5Health News:Growth Opportunity in Brazil's Varicose Vein Treatment Device Market 2Health News:Growth Opportunity in Brazil's Varicose Vein Treatment Device Market 3
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases 28AASLD 29 14321 1Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases 28AASLD 29 14321 2Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases 28AASLD 29 14321 3URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 1URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 2URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 3URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation 5171 4PDL BioPharma Completes October 1 Special Dividend Payment 5167 1
...France, Sept. 11 NicOx S.A.,(Eurolist: COX) today...sclosed promising top-line results from its first ...l entity licensed from NicOx which is a novel,resp... good safety and,tolerability profile, in addition...be beneficial in TOPIGEN,s target indication of Ch...
...1 S*BIO Pte Ltd today announced the,development o...ound,SB1518, for the treatment of myeloproliferati...nancies. MPD is believed to be caused by a specifi...d group of hematological,malignancies in which the...D is characterised by an excess of blood cells and...
Other Medicine Technology:NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 2NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 3NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 4NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results 5S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies 2
...'s CODA® Automated EIA Analyzer is an exceptio...x microplate-based assays. The system's programmin...y laboratories. For low volume users, the software...with common features to complete 9 assays simultan...
...rent available techniques for prenatal diagnosis (... their use a small but significant chance of misca...ers invasive prenatal baby gender testing only to ...bnormalities are greater than or equal to the risk...
...SH pharmDx Kit is a direct fluorescence in situ hy...y determine HER2 gene amplification in formalin-fi...ens. Gene amplification is determined from the rat...ation of the HER2 gene probe (red signals) and the...
...ors in Anesthesia and Respiratory Products, ,West...lity medical devices for Anesthesia and Respirator...facture products that enhance the clinician's abil...lose attention to the bottom line. , ,Our web sit...
Medicine Products: